patrick.net

Those death panels save a lot of money.

Force people to spend obsene gobs of money on insurance premiums that they cant afford. Act all surprised that theres no money left to pay the deductibles, so the sick stay home to avoid bankruptcy. Success!

Those damn deductibles, causing people to go bankrupt !

On the bright side, at least you were able to come up with something.

errc says

Force people to spend obsene gobs of money on insurance premiums that they cant afford. Act all surprised that theres no money left to pay the deductibles, so the sick stay home to avoid bankruptcy. Success!

Eric come get your diploma you graduated. have a nice summer...
marcus says

Those damn deductibles, causing people to go bankrupt !

On the bright side, at least you were able to come up with something.

Marcus I need to see you after school.

tovarichpeter says

in 2010, the actuaries for the Centers for Medicare and Medicaid Services projected

that total national medical spending would increase even more than prior law. Anybody who cares to read can find the current projections, but WaPo prefers to link only to the latest publicists' piece. Per CMS.gov, "spending is projected to grow 1.1 percent faster than Gross Domestic Product (GDP) per year...from 17.4 percent in 2013 to 19.6 percent by 2024." For comparison, that works out to double the UK, where people live longer, and 10x more than Mexico, where people live nearly as long despite the American drug war, wherein the Merida Initiative and Fast&Furious gunwalking have killed more than 100,000 Mexicans. It never ceases to amaze me how the revenue recipients from this legislation (ahem - NOVARTIS - see below - ahem) can believe whatever they choose to maintain their enthusiasm while calling ignorant everyone who has actually read it and predicted accurately what it would do.

For those just tuning in, this thread is yet another automated promotion of Obamneycare brought to you by tovbot, an owned subsidiary of PhRMA:

tovarichpeter says

my son, whose parents were divorced and had difficulty holding jobs, is now a biophysicist at Novartis

For more about PhRMA & Obamneycare, read how "Big Pharma colluded with the White House at the public's expense."

If PhRMA hadn't turned NIH into its own R&D department for daily pills, biophysicists might be able to work independently to invent new cures instead of PhRMA revenue models.

If tovbot's spawn got a job working for the Fed, PatNet readers might be bombarded with endless automated threads daily exhorting us all to buy mortgage backed securities. Although perhaps not spam, tovbot's automated threads illustrate the original Monty Python "spam" sketch.

If the answer to free speech is more speech, then the answer to tovbot's automatic pro-Novartis threads would be something like this:

Prosecutors in Tokyo raided the offices of the Swiss drug maker Novartis on Wednesday as part of an investigation into the alleged use of manipulated data to promote its best-selling blood pressure drug Diovan.

or this:

India's drug regulator has asked Novartis to explain "violations" in papers relating to the manufacturing origin of a veterinary drug, with a European agency having ruled that the document the Swiss company submitted was fake.

or this:

"Obamacare has specifically made negotiating drug prices by the federal government illegal for volume discount purchases, making many drugs unaffordable for patients.

Some, like Novartis' drug Gleevec, cost up to $90,000 per year for cancer treatment for patients, making them unaffordable for thousands suffering from leukemia. Most people in other countries pay for a small fraction of drug costs, but U.S. taxpayers have paid for most of the research and development through the National Institute of Health grants to academic and small private institutions. All the while drug companies reap the monopoly patent-induced profits."

It's tough to compete with a company that manipulates data, submits fake documents, and bribes politicians to mandate monopoly profits off the results of government funded research. It's even tougher if the company is part of an industry group that manipulates government research budgets to convert medical problems into chronic revenue models, rather than finding cures that would restore actual health. Finally, it may become impossible when that industry uses those monopoly profits to buy a tsunami of advertising, PR, and propaganda promoting the legislation that enables the game to continue. I suppose if you can't beat them, join them, but don't expect everyone else to applaud.